Zdrowie i gospodarka · 22/11/2023

FDA Clears Buprenorphine Hydrochloride Injection for Continued Sale

The US Food and Drug Administration (FDA) has determined that Buprenex, a 0.3mg/mL injection, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain on the market and continue to be approved for use in abbreviated new drug applications.